Phase II trial of GVDexa (gemcitabine, vinorelbine and dexamethasone) regimen in relapsed/refractory Hodgkin's lymphoma.

被引：0
|
作者：
Mehra, Nikita
Ganesan, Prasanth
Jayachandran, P. K.
Joel, Anjana
Karunakaran, Parathan
Radhakrishnan, Venkatraman
Ganesan, Trivadi S.
Rathinam, Krishna
Gnana, Sagar Tenali
机构：
[1] Canc Inst WIA, Chennai, Tamil Nadu, India
[2] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
[3] Christian Med Coll, Vellore, Tamil Nadu, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19519
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma
    Ozdemir, Evren
    Aslan, Alma
    Turker, Alev
    Barista, Ibrahim
    Kars, Ayse
    BLOOD, 2015, 126 (23)
  • [32] A multicenter study of a gemcitabine-based regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, Patricia
    Ferme, Christophe
    Brice, Pauline
    Divine, Marine
    Gabarre, Jean
    Bouabdallah, Krimo
    Fitoussi, Olivier
    Chaoui, Driss
    Pacquement, Helene
    Soussain, Carole
    Carde, Patrice
    Sahli, Rafika
    Decaudin, Didier
    BLOOD, 2007, 110 (11) : 178B - 178B
  • [33] A PHASE II TRIAL OF GEMCITABINE, IFOSFAMIDE, DEXAMATHASONE, AND OXALIPLATIN (GIDOX) FOR PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN'S LYMPHOMA
    Park, B. B.
    Kim, W. S.
    Eom, H. S.
    Kim, J. S.
    Oh, S. J.
    Hwang, I. G.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 652 - 652
  • [34] A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, Patricia
    Ferme, Christophe
    Brice, Pauline
    Divine, Marine
    Gabarre, Jean
    Bouabdallah, Krimo
    Fitoussi, Olivier
    Chaoui, Driss
    Pacquement, Helene
    Soussain, Carole
    Carde, Patrice
    Salhi, Rafika
    Zanni, Manuela
    Decaudin, Didier
    ANTI-CANCER DRUGS, 2008, 19 (03) : 309 - 315
  • [35] A multicenter study of a gemcitabine-based regimen in relapsed or refractory Hodgkin's lymphoma patients
    Validire, P.
    Ferme, C.
    Brice, P.
    Divine, M.
    Gabarre, J.
    Bouabdallah, K.
    Fitoussi, O.
    Chaoui, D.
    Pacquement, H.
    Soussain, C.
    Garde, P.
    Salhi, R.
    Decaudin, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 78 - 78
  • [36] A phase I trial with extended cohort of gemcitabine and vinorelbine followed by autologous peripheral blood stream cell transplantation for recurrent or refractory Hodgkin's lymphoma.
    Arai, S
    Negrin, R
    Blume, K
    Johnston, L
    Laport, G
    Lowsky, R
    Shizuru, J
    Stockerl-Golstein, K
    Letsinger, R
    Wong, R
    Horning, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 597S - 597S
  • [37] VINORELBINE, IFOSFAMIDE AND PREDNISOLONE AS A SALVAGE REGIMEN IN RELAPSED HODGKIN'S LYMPHOMA
    Abdel-Halim, I.
    El-ashry, M.
    El-sadda, W.
    ANNALS OF ONCOLOGY, 2010, 21 : 354 - 354
  • [38] Gemcitabine (GEM), cisplatin (P) and methylprednisolone: A salvage regimen in relapsed Hodgkin's disease and non-Hodgkin's lymphoma.
    Waters, J
    Chau, I
    Norman, AR
    Pollard, M
    Wotherspoon, A
    Cunningham, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 579S - 579S
  • [39] High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
    Ryszard Swoboda
    Sebastian Giebel
    Wanda Knopińska-Posłuszny
    Ewa Chmielowska
    Joanna Drozd-Sokołowska
    Ewa Paszkiewicz-Kozik
    Waldemar Kulikowski
    Michał Taszner
    Włodzimierz Mendrek
    Jacek Najda
    Tomasz Czerw
    Magdalena Olszewska-Szopa
    Anna Czyż
    Agnieszka Giza
    Wojciech Spychałowicz
    Edyta Subocz
    Paweł Szwedyk
    Aleksandra Krzywon
    Agata Wilk
    Jan Maciej Zaucha
    Annals of Hematology, 2021, 100 : 1755 - 1767
  • [40] Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
    Bartlett, N. L.
    Niedzwiecki, D.
    Johnson, J. L.
    Friedberg, J. W.
    Johnson, K. B.
    van Besien, K.
    Zelenetz, A. D.
    Cheson, B. D.
    Canellos, G. P.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 1071 - 1079
12345